Preview this article 1 min Biogen is buying a Boston-area biotech that already has two approved drugs to drive short-term and ...

While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

​Biotechnology company Lipella Pharmaceuticals Inc. files for Chapter 11 bankruptcy months after facing Nasdaq delisting.

"This collaboration allows us to explore novel mechanisms and accelerate the identification of promising therapeutic ...

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...

The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.

The Ides of March afflicted the healthcare sector in March. But some key winners also emerged and April is off ... Read More ...

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

Incubate Founder and Executive Director John Stanford spent a busy day on Capitol Hill this week making the case that the ...

On March 30, 2026, Viva Biotech Holdings ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that for the Group's revenue amounted to RMB1,729.4 million during the Reporting ...

LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed ...

Mantis takes disparate sources of data to make synthetic datasets that can be used to build so-called "digital twins" of the ...